| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6280296 | Neuroscience Letters | 2015 | 5 Pages |
Abstract
In conclusion, CSF substance P level was elevated in AD patients and correlated with CSF Aβ1-42 level, a well established marker of senile plaque pathology. The role of low CSF orexin A level in other dementias or SMCI needs to be explored in further studies.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Per Johansson, Erik G. Almqvist, Anders Wallin, Jan-Ove Johansson, Ulf Andreasson, Kaj Blennow, Henrik Zetterberg, Johan Svensson,